|
Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma (mRCC) and brain metastases: Preliminary results from the GETUG-AFU 26 (Nivoren) study. |
| |
|
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Exelixis; Ipsen; Nektar; Novartis; Pfizer; Roche |
Research Funding - Bristol-Myers Squibb (Inst) |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer |
| |
|
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Janssen Oncology; NOVARTIS; SANOFI; Takeda |
| |
|
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Honoraria - Bristol-Myers Squibb; novartis; pfizer; Sanofi |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen Oncology; novartis; pfizer; pfizer |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer |
| |
|
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Novartis; Pfizer |
Travel, Accommodations, Expenses - Novartis; Pfizer |
| |
|
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Ipsen; MSD Oncology; Novartis; Pfizer |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Ipsen (Inst); Novartis; Pfizer; Sanofi |
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Pfizer (Inst) |